Mr. Hassan is director of private equity company Warburg Pincus, and he was previously chair and CEO of Schering-Plough. He also has experience at Pharmacia Corp., Amgen and Precigen. He received his MBA from Harvard Business School in Boston.
Prometheus Biosciences is a biotechnology company focused on diagnostics and treatment of inflammatory bowel disease and other immune-mediated diseases.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
